Neuromuscular blocking agents: Difference between revisions
ClaireLewis (talk | contribs) |
(→Types) |
||
| Line 14: | Line 14: | ||
!Side effects | !Side effects | ||
|- | |- | ||
| ''' | | '''Depolarizing''' | ||
|- | |- | ||
|[[Succinylcholine]] | |[[Succinylcholine]] | ||
| Line 21: | Line 21: | ||
|fasciculations, post-operative pain | |fasciculations, post-operative pain | ||
|- | |- | ||
| '''Depolarizing''' | | '''Non-Depolarizing''' | ||
|- | |- | ||
|[[Vecuronium]] (Norcuron) | |[[Vecuronium]] (Norcuron) | ||
Latest revision as of 00:47, 25 February 2020
Background
- Non-depolarizing
- Competitively block binding of ACh to its receptors
- Depolarizing
- Depolarizing skeletal muscle fiber
- Persistent depolarization makes the muscle fiber resistant to further stimulation by ACh
Types
| Agent | Time to onset (seconds) | Duration (minutes) | Side effects |
|---|---|---|---|
| Depolarizing | |||
| Succinylcholine | fasciculations, post-operative pain | ||
| Non-Depolarizing | |||
| Vecuronium (Norcuron) | 60 | 30–40 | Few, may cause prolonged paralysis and promote muscarinic block |
| Rocuronium (Zemuron) | 75 | 45–70 | may promote muscarinic block |
| Pancuronium (Pavulon) | 90 | 180 or more |
|
See Also
- Reversal agent: Sugammadex